The biology and underlying mechanisms of cross-presentation of exogenous antigens on MHC-I molecules

Annual Review of Immunology

Volumn 35, Issue , 2017, Pages 149-176

  Cruz, Freidrich M ^a   Colbert, Jeff D ^a   Merino, Elena ^a   Kriegsman, Barry A ^a   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antigen presentation; Antigen processing; CD8 T lymphocytes; Dendritic cell; Immune surveillance; Phagosomes

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTING CELL; AUTOPHAGY; CD8+ T LYMPHOCYTE; CROSS PRESENTATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; IMMUNE EVASION; IMMUNE SYSTEM; NONHUMAN; PH; PHAGOCYTE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; IMMUNOLOGY; IMMUNOSURVEILLANCE; LYMPHOCYTE ACTIVATION; METABOLISM; PHAGOCYTOSIS;

ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; LYMPHOCYTE ACTIVATION; PHAGOCYTOSIS;

EID: 85018266736     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-041015-055254     Document Type: Review

References (228)

1. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, et al. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class-I molecules. Cell 78:761-71
2. Rock KL, York IA, Goldberg AL. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5:670-77
3. Townsend A, Trowsdale J. 1993. The transporters associated with antigen presentation. Semin. Cell Biol. 4:53-61
4. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419:480-83
5. York IA, Chang SC, Saric T, Keys JA, Favreau JM, et al. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3:1177-84
6. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ. 1986. Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp. Med. 163:903-21
7. Roche PA, Furuta K. 2015. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15:203-16
8. Bevan MJ. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283-88
9. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959-68
10. Rock KL, Gamble S, Rothstein L. 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918-21
11. Grant EP, Rock KL. 1992.MHCclass I-restricted presentation of exogenous antigen by thymic antigenpresenting cells in vitro and in vivo. J. Immunol. 148:13-18
12. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. PNAS 90:4942-46
13. Shen Z, Reznikoff G, Dranoff G, Rock KL. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723-30
14. Rock KL, Rothstein L, Gamble S, Fleischacker C. 1993. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150:438-46
15. den Haan JMM, Lehar SM, Bevan MJ. 2000. CD8+ but not CD8-dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-96
16. Pooley JL, Heath WR, Shortman K. 2001. Cutting edge: Intravenous soluble antigen is presented to CD4 T cells by CD8-dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166:5327-30
17. Sei JJ, Haskett S, Kaminsky LW, Lin E, Truckenmiller ME, et al. 2015. Peptide-MHC-I from endogenous antigen outnumber those from exogenous antigen, irrespective of APC phenotype or activation. PLOS Pathog. 11:e1004941
18. Mora JR, von Andrian UH. 2006. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 27:235-43
19. Merad M, Sathe P, Helft J, Miller J, Mortha A. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31:563-604
20. Johnson LA, Jackson DG. 2014. Control of dendritic cell trafficking in lymphatics by chemokines. Angiogenesis 17:335-45
21. McDonnell AM, Currie AJ, Brown M, Kania K, Wylie B, et al. 2012. Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation. Oncoimmunology 1:840-46
22. Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ. 2010. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLOS Pathog. 6:e1000768
23. Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, et al. 2008. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 9:155-65
24. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. 1994. Role of bone marrowderived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-65
25. Sigal LJ, Crotty S, Andino R, Rock KL. 1999. Cytotoxic T-cell immunity to virus-infected nonhaematopoietic cells requires presentation of exogenous antigen. Nature 398:77-80
26. Game DS, Lechler RI. 2002. Pathways of allorecognition: implications for transplantation tolerance. Transpl. Immunol. 10:101-8
27. de Jersey J, Snelgrove SL, Palmer SE, Teteris SA, Mullbacher A, et al. 2007. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. PNAS 104:1295-300
28. Calderon B, Unanue ER. 2012. Antigen presentation events in autoimmune diabetes. Curr. Opin. Immunol. 24:119-28
29. Ji Q, Castelli L, Goverman JM. 2013. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells. Nat. Immunol. 14:254-61
30. Sanchez-Paulete AR, Cueto FJ, Martinez-Lopez M, Labiano S, Morales-Kastresana A, et al. 2016. Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov. 6:71-79
31. Iborra S, Izquierdo HM, Martinez-Lopez M, Blanco-Menendez N, Reis e Sousa C, Sancho D. 2012. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J. Clin. Investig. 122:1628-43
32. Smed-Sorensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, et al. 2012. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLOS Pathog. 8:e1002572
33. Shen L, Sigal LJ, Boes M, Rock KL. 2004. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21:155-65
34. Heipertz EL, Davies ML, Lin E, Norbury CC. 2014. Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation. J. Immunol. 193:4169-77
35. Aleyas AG, Han YW, Patil AM, Kim SB, Kim K, Eo SK. 2012. Impaired cross-presentation of CD8a+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner. Eur. J. Immunol. 42:2655-66
36. Lenschow DJ, Walunas TL, Bluestone JA. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-58
37. Luckashenak N, Schroeder S, Endt K, Schmidt D, Mahnke K, et al. 2008. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28:521-32
38. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. 1997. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J. Exp. Med. 186:239-45
39. Gallegos AM, Bevan MJ. 2004. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200:1039-49
40. Falo LD Jr., Kovacsovics-Bankowski M, Thompson K, Rock KL. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649-53
41. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-62
42. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783-91
43. van Montfoort N, Mangsbo SM, Camps MG, van Maren WW, Verhaart IE, et al. 2012. Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur. J. Immunol. 42:598-606
44. Burgdorf S, Lukacs-Kornek V, Kurts C. 2006. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 176:6770-76
45. Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC. 2010. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J. Immunol. 185:3426-35
46. Kerksiek KM, Niedergang F, Chavrier P, Busch DH, Brocker T. 2005. Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood 105:742-49
47. Subramanian M, Hayes CD, Thome JJ, Thorp E, Matsushima GK, et al. 2014. An AXL/LRP-1/RANBP9 complexmediates DC efferocytosis and antigen cross-presentation in vivo. J. Clin. Investig. 124:1296-308
48. Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S, et al. 2012. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virusinfected mice. J. Clin. Investig. 122:1615-27
49. Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, et al. 2012. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood 119:2284-92
50. Anyaegbu CC, Lake RA, Heel K, Robinson BW, Fisher SA. 2014. Chemotherapy enhances crosspresentation of nuclear tumor antigens. PLOS ONE 9:e107894
51. Shen L, Rock KL. 2004. Cellular protein is the source of cross-priming antigen in vivo. PNAS 101:3035-40
52. Li Y, Wang LX, Yang G, Hao F, Urba WJ, Hu HM. 2008. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 68:6889-95
53. Joubert PE, Albert ML. 2012. Antigen cross-priming of cell-associated proteins is enhanced by macroautophagy within the antigen donor cell. Front. Immunol. 3:61
54. Basu S, Srivastava PK. 2000. Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones 5:443-51
55. Matheoud D, Perie L, Hoeffel G, Vimeux L, Parent I, et al. 2010. Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo. Blood 115:4412-20
56. Matheoud D, Baey C, Vimeux L, Tempez A, Valente M, et al. 2011. Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model. PLOS ONE 6:e19104
57. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7:297-303
58. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. 2003. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J. Immunol. 170:2302-9
59. Neijssen J, Herberts C, Drijfhout JW, Reits E, Janssen L, Neefjes J. 2005. Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434:83-88
60. Smyth LA, Hervouet C, Hayday T, Becker PD, Ellis R, et al. 2012. Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo. J. Immunol. 189:2274-82
61. Li L, Kim S, Herndon JM, Goedegebuure P, Belt BA, et al. 2012. Cross-dressed CD8a+/CD103+ dendritic cells prime CD8+ T cells following vaccination. PNAS 109:12716-21
62. Dolan BP, Gibbs KD Jr., Ostrand-Rosenberg S. 2006. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J. Immunol. 177:6018-24
63. Serna A, Ramirez MC, Soukhanova A, Sigal LJ. 2003. Cutting edge: Efficient MHC class I crosspresentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171:5668-72
64. Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, et al. 2004. CD8+ T cell crosspriming via transfer of proteasome substrates. Science 304:1318-21
65. Wang J, Nanjundappa RH, Shameli A, Clemente-Casares X, Yamanouchi J, et al. 2014. The crosspriming capacity and direct presentation potential of an autoantigen are separable and inversely related properties. J. Immunol. 193:3296-307
66. Schliehe C, Bitzer A, van den Broek M, Groettrup M. 2012. Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. J. Virol. 86:9782-93
67. Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, et al. 2006. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. PNAS 103:10729-34
68. Wakim LM, Bevan MJ. 2011. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 471:629-32
69. Goldszmid RS, Coppens I, Lev A, Caspar P, Mellman I, Sher A. 2009. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J. Exp. Med. 206:399-410
70. Bertholet S, Goldszmid R, Morrot A, Debrabant A, Afrin F, et al. 2006. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J. Immunol. 177:3525-33
71. Harriff MJ, Burgdorf S, Kurts C, Wiertz EJ, Lewinsohn DA, Lewinsohn DM.2013.TAP mediates import of Mycobacterium tuberculosis-derived peptides into phagosomes and facilitates loading onto HLA-I. PLOS ONE 8:e79571
72. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. PNAS 89:12013-17
73. Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, et al. 2002. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168:3992-4000
74. Ersching J, Vasconcelos JR, Ferreira CP, Caetano BC, Machado AV, et al. 2016. The combined deficiency of immunoproteasome subunits affects both the magnitude and quality of pathogen-and genetic vaccination-induced CD8+ T cell responses to the human protozoan parasite Trypanosoma cruzi. PLOS Pathog. 12:e1005593
75. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. 2005. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6:107-13
76. Kovacsovics-Bankowski M, Rock KL. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243-46
77. Fonteneau JF, Kavanagh DG, Lirvall M, Sanders C, Cover TL, et al. 2003. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102:4448-55
78. Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, et al. 2006. Role of immunoproteasomes in cross-presentation. J. Immunol. 177:983-90
79. Lin ML, Zhan Y, Proietto AI, Prato S, Wu L, et al. 2008. Selective suicide of cross-presentingCD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. PNAS 105:3029-34
80. Imai T, Kato Y, Kajiwara C, Mizukami S, Ishige I, et al. 2011. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. PNAS 108:16363-68
81. Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. 2008. Spatial and mechanistic separation of crosspresentation and endogenous antigen presentation. Nat. Immunol. 9:558-66
82. Cebrian I, Visentin G, Blanchard N, Jouve M, Bobard A, et al. 2011. Sec 22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 147:1355-68
83. Ma W, Zhang Y, Vigneron N, Stroobant V, Thielemans K, et al. 2016. Long-peptide cross-presentation by human dendritic cells occurs in vacuoles by peptide exchange on nascent MHC class I molecules. J. Immunol. 196:1711-20
84. Song R, Harding CV. 1996. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:4182-90
85. Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hammerling GJ, Momburg F. 2007. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J. Immunol. 178:7932-42
86. Hari A, Ganguly A, Mu L, Davis SP, Stenner MD, et al. 2015. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis. Eur. J. Immunol. 45:383-95
87. Harding CV, Song R. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925-33
88. Potter NS, Harding CV. 2001. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J. Immunol. 167:2538-46
89. Oh YK, Swanson JA. 1996. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J. Cell Biol. 132:585-93
90. Mant A, Chinnery F, Elliott T, Williams AP. 2012. The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen. Immunology 136:163-75
91. Merzougui N, Kratzer R, Saveanu L, van Endert P. 2011. A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen. EMBO Rep. 12:1257-64
92. Belizaire R, Unanue ER. 2009. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. PNAS 106:17463-68
93. Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, et al. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402-6
94. Campbell-Valois FX, Trost M, Chemali M, Dill BD, Laplante A, et al. 2012. Quantitative proteomics reveals that only a subset of the endoplasmic reticulum contributes to the phagosome. Mol. Cell Proteom. 11:M111 016378
95. Ruggiano A, Foresti O, Carvalho P. 2014. Quality control: ER-associated degradation; protein quality control and beyond. J. Cell Biol. 204:869-79
96. Grotzke JE, Cresswell P. 2015. Are ERAD components involved in cross-presentation? Mol. Immunol. 68:112-15
97. Ye Y, Meyer HH, Rapoport TA. 2001. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414:652-56
98. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, et al. 1996. Sec 61-mediated transfer of amembrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432-38
99. Mehnert M, Sommer T, Jarosch E. 2014. Der1 promotes movement of misfolded proteins through the endoplasmic reticulum membrane. Nat. Cell Biol. 16:77-86
100. Carvalho P, Stanley AM, Rapoport TA. 2010. Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p. Cell 143:579-91
101. Ackerman AL, Giodini A, Cresswell P. 2006. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25:607-17
102. Zehner M, Chasan AI, Schuette V, Embgenbroich M, Quast T, et al. 2011. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for crosspresentation. PNAS 108:9933-38
103. Menager J, Ebstein F, Oger R, Hulin P, Nedellec S, et al. 2014. Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but not sec61 and/or Derlin-1. PLOS One 9:e89897
104. Imai J, Hasegawa H, Maruya M, Koyasu S, Yahara I. 2005. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. Int. Immunol. 17:45-53
105. Zehner M, Marschall AL, Bos E, Schloetel JG, Kreer C, et al. 2015. The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8+ T cells. Immunity 42:850-63
106. Singh R, Cresswell P. 2010. Defective cross-presentation of viral antigens in GILT-free mice. Science 328:1394-98
107. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9:847-56
108. Giodini A, Cresswell P. 2008. Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells. EMBO J. 27:201-11
109. Dingjan I, Verboogen DR, Paardekooper LM, Revelo NH, Sittig SP, et al. 2016. Lipid peroxidation causes endosomal antigen release for cross-presentation. Sci. Rep. 6:22064
110. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, et al. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126:205-18
111. Johansson AC, Appelqvist H, Nilsson C, Kagedal K, Roberg K, Ollinger K. 2010. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 15:527-40
112. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. 2003. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425:397-402
113. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. 2003. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. PNAS 100:12889-94
114. Lawand M, Abramova A, Manceau V, Springer S, van Endert P. 2016. TAP-dependent and -independent peptide import into dendritic cell phagosomes. J. Immunol. 197:3454-63
115. Saveanu L, Carroll O, Weimershaus M, Guermonprez P, Firat E, et al. 2009. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 325:213-17
116. Weimershaus M, Maschalidi S, Sepulveda F, Manoury B, van Endert P, Saveanu L. 2012. Conventional dendritic cells require IRAP-Rab14 endosomes for efficient cross-presentation. J. Immunol. 188:1840-46
117. Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL. 2001. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20:2357-66
118. Rock KL, Farfan-Arribas DJ, Shen L. 2010. Proteases in MHC class I presentation and crosspresentation. J. Immunol. 184:9-15
119. Saveanu L, Babdor J, Lawand M, van Endert P. 2013. Insulin-regulated aminopeptidase and its compartment in dendritic cells. Mol. Immunol. 55:153-55
120. Basha G, Lizee G, Reinicke AT, Seipp RP, Omilusik KD, Jefferies WA. 2008. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells. PLOS ONE3:e3247
121. Crespo MI, Zacca ER, Nunez NG, Ranocchia RP, Maccioni M, et al. 2013. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8a+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface. J. Immunol. 190:948-60
122. Ramachandra L, Sramkoski RM, Canaday DH, Boom WH, Harding CV. 1998. Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes. J. Immunol. Methods 213:53-71
123. Lizee G, Basha G, Tiong J, Julien JP, Tian M, et al. 2003. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4:1065-73
124. Zou L, Zhou J, Zhang J, Li J, Liu N, et al. 2009. The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells. PNAS 106:15801
125. Cebrian I, Croce C, Guerrero NA, Blanchard N, Mayorga LS. 2016. Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells. EMBO Rep. 17:1499-671
126. Weigert R, Yeung AC, Li J, Donaldson JG. 2004. Rab22a regulates the recycling of membrane proteins internalized independently of clathrin. Mol. Biol. Cell 15:3758-70
127. Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, et al. 2014. TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 158:506-21
128. Singh SK, Streng-Ouwehand I, Litjens M, Kalay H, Saeland E, van Kooyk Y. 2011. Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. Int. J. Cancer 128:1371-83
129. Weck MM, Grunebach F, Werth D, Sinzger C, Bringmann A, Brossart P. 2007. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109:3890-94
130. Sugita M, Brenner MB. 1995. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270:1443-48
131. Basha G, Omilusik K, Chavez-Steenbock A, Reinicke AT, Lack N, et al. 2012. ACD74-dependentMHC class I endolysosomal cross-presentation pathway. Nat. Immunol. 13:237-45
132. Ljunggren HG, Stam NJ, Ohlen C, Neefjes JJ, Hoglund P, et al. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476-80
133. Pos W, Sethi DK, Wucherpfennig KW. 2013. Mechanisms of peptide repertoire selection by HLA-DM. Trends Immunol. 34:495-501
134. Hulpke S, Tampe R. 2013. TheMHCI loading complex: amultitaskingmachinery in adaptive immunity. Trends Biochem. Sci. 38:412-20
135. Chefalo PJ, Grandea AG 3rd, Van Kaer L, Harding CV. 2003. Tapasin-/-and TAP1-/-macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol. 170:5825-33
136. Accapezzato D, Visco V, Francavilla V, Molette C, Donato T, et al. 2005. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J. Exp. Med. 202:817-28
137. Mantegazza AR, Savina A, Vermeulen M, Perez L, Geffner J, et al. 2008. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112:4712-22
138. Savina A, Peres A, Cebrian I, Carmo N, Moita C, et al. 2009. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively inCD8+ dendritic cells. Immunity 30:544-55
139. Jancic C, Savina A, Wasmeier C, Tolmachova T, El-Benna J, et al. 2007. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat. Cell Biol. 9:367-78
140. Graham DB, Stephenson LM, Lam SK, Brim K, Lee HM, et al. 2007. An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells. J. Exp. Med. 204:2889-97
141. Samie M, Cresswell P. 2015. The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways. Nat. Immunol. 16:729-36
142. Rizzitelli A, Meuter S, Vega Ramos J, Bird CH, Mintern JD, et al. 2012. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation. Immunol. Cell Biol. 90:841-51
143. Bougneres L, Helft J, Tiwari S, Vargas P, Chang BH, et al. 2009. A role for lipid bodies in the crosspresentation of phagocytosed antigens by MHC class I in dendritic cells. Immunity 31:232-44
144. Neefjes JJ, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171-83
145. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316:612-16
146. Chatterjee B, Smed-Sorensen A, Cohn L, Chalouni C, Vandlen R, et al. 2012. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood 120:2011-20
147. Shen KY, Song YC, Chen IH, Leng CH, Chen HW, et al. 2014. Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells. J. Immunol. 192:4233-41
148. Murrow L, Debnath J. 2013. Autophagy as a stress-response and quality-controlmechanism: implications for cell injury and human disease. Annu. Rev. Pathol. 8:105-37
149. Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, et al. 2010. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32:227-39
150. Ravindran R, Khan N, Nakaya HI, Li S, Loebbermann J, et al. 2014. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 343:313-17
151. Li H, Li Y, Jiao J, Hu HM. 2011. Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat. Nanotechnol. 6:645-50
152. Mintern JD, Macri C, Chin WJ, Panozza SE, Segura E, et al. 2015. Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Autophagy 11:906-17
153. Martinez J, Malireddi RK, Lu Q, Cunha LD, Pelletier S, et al. 2015. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17:893-906
154. Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, et al. 2007. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450:1253-57
155. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, et al. 2008. Batf3 deficiency reveals a critical role for CD8a+ dendritic cells in cytotoxic T cell immunity. Science 322:1097-100
156. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, et al. 2002. In vivo depletion ofCD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17:211-20
157. Chiang MC, Tullett KM, Lee YS, Idris A, Ding Y, et al. 2016. Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets. Eur. J. Immunol. 46:329-39
158. Tel J, Sittig SP, Blom RA, Cruz LJ, Schreibelt G, et al. 2013. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion. J. Immunol. 191:5005-12
159. Nierkens S, Tel J, Janssen E, Adema GJ. 2013. Antigen cross-presentation by dendritic cell subsets: One general or all sergeants? Trends Immunol. 34:361-70
160. Segura E, Durand M, Amigorena S. 2013. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J. Exp. Med. 210:1035-47
161. Kitano M, Yamazaki C, Takumi A, Ikeno T, Hemmi H, et al. 2016. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node. PNAS 113:1044-49
162. Busche A, Jirmo AC, Welten SP, Zischke J, Noack J, et al. 2013. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. J. Immunol. 190:2767-77
163. Becker M, Guttler S, Bachem A, Hartung E, Mora A, et al. 2014. Ontogenic, phenotypic, and functional characterization of XCR1+ dendritic cells leads to a consistent classification of intestinal dendritic cells based on the expression of XCR1 and SIRPa. Front. Immunol. 5:326
164. Cerovic V, Houston SA, Westlund J, Utriainen L, Davison ES, et al. 2015. Lymph-borne CD8a+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells. Mucosal Immunol. 8:38-48
165. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, et al. 2009. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10:488-95
166. Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, et al. 2010. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207:189-206
167. Desch AN, Randolph GJ, Murphy K, Gautier EL, Kedl RM, et al. 2011. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208:1789-97
168. Wagner CS, Grotzke J, Cresswell P. 2013. Intracellular regulation of cross-presentation during dendritic cell maturation. PLOS ONE 8:e76801
169. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, et al. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153-62
170. Cohn L, Chatterjee B, Esselborn F, Smed-Sorensen A, Nakamura N, et al. 2013. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J. Exp. Med. 210:1049-63
171. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, et al. 2012. Human tissues contain CD141hi crosspresenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37:60-73
172. Hanc P, Fujii T, Iborra S, Yamada Y, Huotari J, et al. 2015. Structure of the complex of F-actin and DNGR-1, a C-type lectin receptor involved in dendritic cell cross-presentation of dead cell-associated antigens. Immunity 42:839-49
173. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315:107-11
174. Ding Y, Guo Z, Liu Y, Li X, Zhang Q, et al. 2016. The lectin Siglec-G inhibits dendritic cell crosspresentation by impairing MHC class I-peptide complex formation. Nat. Immunol. 17:1167-75
175. Nizza ST, Campbell JJ. 2014. CD11b+ migratory dendritic cells mediate CD8 T cell cross-priming and cutaneous imprinting after topical immunization. PLOS ONE 9:e91054
176. Ballesteros-Tato A, Leon B, Lund FE, Randall TD. 2010. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza. Nat. Immunol. 11:216-24
177. Backer R, vanLeeuwen F, Kraal G, denHaan JM. 2008.CD8-dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens. Eur. J. Immunol. 38:370-80
178. Desch AN, Gibbings SL, Clambey ET, Janssen WJ, Slansky JE, et al. 2014. Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction. Nat. Commun. 5:4674
179. Segura E, Albiston AL, Wicks IP, Chai SY, Villadangos JA. 2009. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. PNAS 106:20377-81
180. den Haan JMM, Bevan MJ. 2002. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8+and CD8-dendritic cells in vivo. J. Exp. Med. 196:817-27
181. Mount AM, Smith CM, Kupresanin F, Stoermer K, Heath WR, Belz GT. 2008. Multiple dendritic cell populations activate CD4+ T cells after viral stimulation. PLOS ONE 3:e1691
182. Savina A, Amigorena S. 2007. Phagocytosis and antigen presentation in dendritic cells. Immunol. Rev. 219:143-56
183. Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, et al. 2011. CD169-positivemacrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34:85-95
184. Leiriao P, del Fresno C, Ardavin C. 2012. Monocytes as effector cells: Activated Ly-6Chigh mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells. Eur. J. Immunol. 42:2042-51
185. Davey MS, Morgan MP, Liuzzi AR, Tyler CJ, Khan MW, et al. 2014. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J. Immunol. 193:3704-16
186. Milo I, Sapoznikov A, Kalchenko V, Tal O, Krauthgamer R, et al. 2013. Dynamic imaging reveals promiscuous crosspresentation of blood-borne antigens to naive CD8+ T cells in the bone marrow. Blood 122:193-208
187. Kiesel JR, Buchwald ZS, Aurora R. 2009. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J. Immunol. 182:5477-87
188. Ebrahimkhani MR, Mohar I, Crispe IN. 2011. Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology 54:1379-87
189. Jarry U, Jeannin P, Pineau L, Donnou S, Delneste Y, Couez D. 2013. Efficiently stimulated adult microglia cross-prime naive CD8+ T cells injected in the brain. Eur. J. Immunol. 43:1173-84
190. Hirosue S, Vokali E, Raghavan VR, Rincon-Restrepo M, Lund AW, et al. 2014. Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells. J. Immunol. 192:5002-11
191. Giodini A, Rahner C, Cresswell P. 2009. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. PNAS 106:3324-29
192. Perchellet A, Brabb T, Goverman JM. 2008. Crosspresentation by nonhematopoietic and direct presentation by hematopoietic cells induce central tolerance to myelin basic protein. PNAS 105:14040-45
193. Ke Y, Kapp JA. 1996. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J. Exp. Med. 184:1179-84
194. Marino E, Tan B, Binge L, Mackay CR, Grey ST. 2012. B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes 61:2893-905
195. Goodridge JP, Lee N, Burian A, Pyo CW, Tykodi SS, et al. 2013. HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J. Immunol. 191:1567-77
196. van deWeijer ML, Luteijn RD, Wiertz EJ. 2015. Viral immune evasion: lessons in MHC class I antigen presentation. Semin. Immunol. 27:125-37
197. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-42
198. Nopora K, Bernhard CA, Ried C, Castello AA, Murphy KM, et al. 2012.MHCclass I cross-presentation by dendritic cells counteracts viral immune evasion. Front. Immunol. 3:348
199. Orr MT, Edelmann KH, Vieira J, Corey L, Raulet DH, Wilson CB. 2005. Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. PLOS Pathog. 1:e7
200. Gainey MD, Rivenbark JG, Cho H, Yang L, Yokoyama WM. 2012. ViralMHCclass I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming. PNAS 109:E3260-67
201. Matheoud D, Moradin N, Bellemare-Pelletier A, Shio MT, Hong WJ, et al. 2013. Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8. Cell Host Microbe 14:15-25
202. Ribeiro-Gomes FL, Romano A, Lee S, Roffe E, Peters NC, et al. 2015. Apoptotic cell clearance of Leishmania major-infected neutrophils by dendritic cells inhibits CD8+ T-cell priming in vitro by Mer tyrosine kinase-dependent signaling. Cell Death Dis. 6:e2018
203. Ramakrishnan R, Tyurin VA, Veglia F, Condamine T, Amoscato A, et al. 2014. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J. Immunol. 192:2920-31
204. McDonnell AM, Lesterhuis WJ, Khong A, Nowak AK, Lake RA, et al. 2015. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur. J. Immunol. 45:49-59
205. Belz GT, Heath WR, Carbone FR. 2002. The role of dendritic cell subsets in selection between tolerance and immunity. Immunol. Cell Biol. 80:463-68
206. Lutz MB, Kurts C. 2009. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell crosstolerance by dendritic cells. Eur. J. Immunol. 39:2325-30
207. Kapsenberg ML. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3:984-93
208. Shi Y, Evans JE, Rock KL. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-21
209. Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, et al. 2014. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41:830-42
210. Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, et al. 2011. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J. Clin. Investig. 121:4746-57
211. Kerkar SP, Chinnasamy D, Hadi N, Melenhorst J, Muranski P, et al. 2014. Timing and intensity of exposure to interferon-gamma critically determines the function of monocyte-derived dendritic cells. Immunology 143:96-108
212. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, et al. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887-92
213. Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, et al. 2003. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170:4102-10
214. Elsen S, Doussiere J, Villiers CL, Faure M, Berthier R, et al. 2004. Cryptic O2-generating NADPH oxidase in dendritic cells. J. Cell Sci. 117:2215-26
215. Alloatti A, Kotsias F, Pauwels AM, Carpier JM, JouveM, et al. 2015. Toll-like receptor 4 engagement on dendritic cells restrains phago-lysosome fusion and promotes cross-presentation of antigens. Immunity 43:1087-100
216. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749-95
217. Schiavoni G, Mattei F, Gabriele L. 2013. Type I interferons as stimulators of DC-mediated crosspriming: impact on anti-tumor response. Front. Immunol. 4:483
218. Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, et al. 2011. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208:1989-2003
219. Wilson NS, Behrens GM, Lundie RJ, Smith CM, Waithman J, et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7:165-72
220. Wong YC, Smith SA, Tscharke DC. 2013. Systemic Toll-like receptor ligation and selective killing of dendritic cell subsets fail to dissect priming pathways for anti-vaccinia virus CD8+ T cells. J. Virol. 87:11978-86
221. Wagner CS, Cresswell P. 2012. TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation. J. Immunol. 188:686-93
222. Raychaudhuri S, Rock KL. 1998. Fully mobilizing host defense: building better vaccines. Nat. Biotechnol. 16:1025-31
223. Platzer B, Stout M, Fiebiger E. 2014. Antigen cross-presentation of immune complexes. Front. Immunol. 5:140
224. Hartung E, Becker M, Bachem A, Reeg N, Jakel A, et al. 2015. Induction of potentCD8Tcell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1. J. Immunol. 194:1069-79
225. Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, et al. 2010. Mature dendritic cells use endocytic receptors to capture and present antigens. PNAS 107:4287-92
226. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627-38
227. Herve J, Dubreil L, Tardif V, Terme M, Pogu S, et al. 2013.β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J. Immunol. 190:3163-71
228. Hunzeker JT, Elftman MD, Mellinger JC, Princiotta MF, Bonneau RH, et al. 2011. Amarked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells. J. Immunol. 186:183-94